Illustration: Aïda Amer/Axios
Capital Rx, a pharmacy benefit management (PBM) startup, is raising $400 million led by Wellington Management and General Catalyst.
Why it matters: The company bills itself as a transparent alternative to the perennially scrutinized traditional PBM model.
